Dr. Mark L. Sobczak MD Radiation Oncologist
Dr. Mark Sobczak is a radiation oncologist in Philadelphia, Pennsylvania and is affiliated with Fox Chase Cancer Center-American Oncologic Hospital. He received his medical degree from Uniformed Services University of the Health Sciences and has been in practice for 12 years. Dr. Sobczak accepts several types of health insurance, listed below. He is one of 10 doctors at Fox Chase Cancer Center-American Oncologic Hospital who specialize in Radiation Oncology.
Are you Dr. Mark Sobczak? Claim your profile to make edits or add details.Edit Profile
Specialty & Clinical Interests
Radiation Oncologist: General Radiation Oncology
Clinical Interests: Genitourinary Malignancies, Age Factors, Antineoplastic Combined Chemotherapy Protocols, Combined Modality Therapy, Prostatic Neoplasms, Androgen Antagonists, Drug Administration Schedule, Estramustine, Etoposide
Fox Chase Cancer Center-American Oncologic Hospital
Ranked #30 in Cancer
Education & Medical Training
Massachusetts General Hospital
Residency, Radiation Oncology, 1988 - 1991
National Capital Consortium
Internship, Transitional Year, 1987 - 1988
Uniformed Services University of the Health Sciences
Class of 1987
Massachusetts Gen Hosp
Residency, Radiation Oncology, 1998 - 2001
Certifications & Licensure
American Board of Radiology
Certified 22 years in Radiation Oncology
DE State Medical License
Active through 2013
NJ State Medical License
Active through 2013
PA State Medical License
Active through 2012
Awards, Honors & Recognition
Meaningful Use Stage 1 Certification,
Centers for Medicare & Medicaid Services
Philadelphia Top Doc,
Main Line Times
Publications & Presentations
Gleason Scoring at a Comprehensive Cancer Center: What's The Difference?
Townsend, N. C.,Ruth, K.,Al-Saleem, T.,Horwitz, E. M.,Sobczak, M.,Uzzo, R. G.,Viterbo, R.,Buyyounouski, M. K.
Young age under 60 years is not a contraindication to treatment with definitive dose escalated radiotherapy for prostate cancer.
Klayton, T. L., Ruth, K., Horwitz, E. M., Uzzo, R. G., Kutikov, A., Chen, D. Y., Sobczak, M., Buyyounouski, M. K.
Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-ris
Rosenthal, S. A., Bae, K., Pienta, K. J., Sobczak, M. L., Asbell, S. O., Rajan, R., Kerlin, K. J., Michalski, J. M., Sandler, H. M.
- Aetna Choice POS II
- Aetna HMO
- AmeriHealth Direct POS
- Amerihealth HMO
- AmeriHealth PPO
- BCBS Blue Card PPO
- BCBS California CaliforniaCare HMO
- BCBS California PowerSelect HMO
- BCBS California PPO
- BCBS Texas BlueChoice
- Blue Shield California HMO
- Blue Shield California PPO
- CIGNA HMO
- CIGNA Open Access
- CIGNA PPO
- First Health PPO
- Great West PPO
- Health Net California Large Group PPO
- Health Net HMO - Employer Group
- HealthAmerica HealthAssurance PPO
- Humana ChoiceCare Network PPO
- IBC Keystone HMO / POS
- IBC Personal Choice PPO
- Multiplan PHCS PPO
- Multiplan PHCS PPO - Kaiser
- Multiplan PPO
- Pacificare HMO
- QualCare HMO
- QualCare PPO
- United Healthcare - Direct Choice Plus POS
- United Healthcare - Direct Options PPO
Help Us Keep the "U.S. News Doctor Finder" Current
If you are aware of information on this pagethat is out of date or incorrect, please let us know.
*Required Field | Your email will not be used for marketing.
Your Message Has Been Submitted
As part of our research on the correction you submitted, you may be contacted at the email address provided.
Sorry, Your Message Could Not Be Submitted
Please try again later, or E-mail your message to firstname.lastname@example.org and include the Web address (URL) of the page that contains incorrect information.
333 Cottman Ave
Philadelphia, PA 19111
Phone: (215) 728-6900